Pamela Russell
Pamela Russell
Professor Pamela J Russell (nee Giltinan), QUT
Verified email at qut.edu.au
TitleCited byYear
Biology and management of bladder cancer
D Raghavan, WU Shipley, MB Garnick, PJ Russell, JP Richie
New England Journal of Medicine 322 (16), 1129-1138, 1990
4931990
Biology and management of bladder cancer
D Raghavan, WU Shipley, MB Garnick, PJ Russell, JP Richie
New England Journal of Medicine 322 (16), 1129-1138, 1990
4931990
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh, LM Sapinoso, SG Kern, DA Brown, T Liu, AR Bauskin, RL Ward, ...
Proceedings of the National Academy of Sciences 100 (6), 3410-3415, 2003
4052003
Growth factor involvement in progression of prostate cancer
PJ Russell, S Bennett, P Stricker
Clinical Chemistry 44 (4), 705-723, 1998
2851998
Detailed methylation analysis of the glutathione S-transferase π(GSTP 1) gene in prostate cancer
DS Millar, KK Ow, CL Paul, PJ Russell, PL Molloy, SJ Clark
Oncogene 18 (6), 1313-1324, 1999
2511999
Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells
T Liu, AR Bauskin, J Zaunders, DA Brown, S Pankurst, PJ Russell, ...
Cancer research 63 (16), 5034-5040, 2003
2202003
The role of nonlymphoid accessory cells in the immune response to different antigens
K Shortman, E Diener, P Russell, WD Armstrong
Journal of Experimental Medicine 131 (3), 461-482, 1970
1961970
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene
DS O’Keefe, SL Su, DJ Bacich, Y Horiguchi, Y Luo, CT Powell, ...
Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1443 (1-2 …, 1998
1911998
THE SEPARATION OF DIFFERENT CELL CLASSES FROM LYMPHOID ORGANS: IV. The Separation of Lymphocytes from Phagocytes on Glass Bead Columns, and Its Effect on Subpopulations of …
K Shortman, N Williams, H Jackson, P Russell, P Byrt, E Diener
The Journal of cell biology 48 (3), 566-579, 1971
1731971
Urokinase‐type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer‐specific survival and potential therapeutic …
JL Yang, D Seetoo, Y Wang, M Ranson, CR Berney, JM Ham, PJ Russell, ...
International journal of cancer 89 (5), 431-439, 2000
1502000
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome
AR Bauskin, DA Brown, S Junankar, KK Rasiah, S Eggleton, M Hunter, ...
Cancer research 65 (6), 2330-2336, 2005
1372005
Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
Y Yu, JL Yang, B Markovic, P Jackson, G Yardley, J Barrett, PJ Russell
Clinical cancer research 3 (7), 1045-1049, 1997
1271997
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis
DA Brown, C Stephan, RL Ward, M Law, M Hunter, AR Bauskin, J Amin, ...
Clinical cancer research 12 (1), 89-96, 2006
1252006
MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer
PJ Cozzi, J Wang, W Delprado, AC Perkins, BJ Allen, PJ Russell, Y Li
Clinical & experimental metastasis 22 (7), 565-573, 2005
1232005
Emerging roles for phospholipase A< sub> 2</sub> enzymes in cancer
KF Scott, M Sajinovic, J Hein, S Nixdorf, P Galettis, W Liauw, P de Souza, ...
Biochimie 92 (6), 601-610, 2010
1222010
Cyclophosphamide treatment of renal disease in (NZB× NZW) F1 hybrid mice
PJ Russell, JD Hicks
The Lancet 291 (7540), 440-446, 1968
1221968
Engineered silk fibroin protein 3D matrices for in vitro tumor model
S Talukdar, M Mandal, DW Hutmacher, PJ Russell, C Soekmadji, ...
Biomaterials 32 (8), 2149-2159, 2011
1162011
Paraffin section storage and immunohistochemistry: effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen
K Wester, E Wahlund, C Sundström, P Ranefall, E Bengtsson, PJ Russell, ...
Applied Immunohistochemistry & Molecular Morphology 8 (1), 61-70, 2000
1152000
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors
R Martiniello-Wilks, J Garcia-Aragon, MM Daja, P Russell, GW Both, ...
Human gene therapy 9 (11), 1617-1626, 1998
1111998
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J Hao, H Chen, MC Madigan, PJ Cozzi, J Beretov, W Xiao, WJ Delprado, ...
British journal of cancer 103 (7), 1008-1018, 2010
1092010
The system can't perform the operation now. Try again later.
Articles 1–20